
AI / Fri 29 Sep 2023
Cambridge-based chip designer Arm has confirmed its valuation of $54.5bn (£43.6bn) ahead of its IPO...
Mercia Ventures has led a £1.8m seed financing round into the Cambridge-based AI drug-finding start...
British chip designer Arm is targeting a valuation of more than $50bn (£40bn) for its hotly anticip...
Cambridge-based biotech company Abcam has been acquired by US medical and diagnostic tool developer ...
Chip company Arm has filed a registration statement in a significant step towards its public listing...
THG founder and CEO Matthew Moulding has called out a US hedge fund for short-selling Darktrace in a...